“celgene” Archives

in
Entry Author Date Location
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal 06/12/17 Boston
Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More 05/26/17 National
Celgene’s Data Could Lead To New Option For Multiple Sclerosis Patients 05/22/17 New York
Ex-Sarepta CEO Garabedian Returns to Run Bio Accelerator Xontogeny 05/18/17 Boston
Zymeworks Bags $58M in IPO to Bankroll Cancer Drug Trials 04/28/17 Seattle
OncoMed Slashes Workforce After Two Clinical Trial Failures in Cancer 04/24/17 San Francisco
OncoMed Shares Sink as One Drug Fails, Bayer Kicks Back Two Others 04/10/17 San Francisco
Third Rock’s Tango Aims For Drugs That Turn Cancer Against Itself 03/30/17 Boston
Invenra Adds Partners, Still Open to Developing Own Drugs in Future 03/14/17 Wisconsin
Drugmakers, Amazon Back Grail’s Big Cancer Trials With $900M 03/01/17 San Francisco
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills 02/27/17 Boston
Harvard’s Verdine Aims to Retire, Become Full-Time FogPharma CEO 02/23/17 Boston
Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More 02/17/17 National
With $20M, UCSD Spinout Jecure To Press New Attack On NASH 02/15/17 San Diego
Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins 02/03/17 National
Drug-Hunting Startup From Scripps Attracts Celgene Alum, $50M Backing 02/02/17 San Diego
Bio Roundup: Trump News, Anthem’s Stand, Diversity by 2056 & More 01/27/17 National
Jounce Gets $102M As Biotech IPOs Gain Steam in ’17 01/27/17 Boston
AnaptysBio Adds More Shares, Raises $75M in Stock Market Debut 01/26/17 San Diego
Just Four Months After Series A, Delinia Sells to Celgene For $300M 01/26/17 Boston
Celgene Pays Anokion $45M for Autoimmune Research, Option to Buy 01/09/17 New York
Versant Closes on $400M Fund, Eyes More Biotech Deals in Europe 01/03/17 San Francisco
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) 12/22/16 National
After FDA Hold, Agios Quickly Scraps One Anemia Drug, Turns to Another 12/15/16 Boston
BlueRock Raises $225M To Repair Heart Damage With Stem Cells 12/12/16 Boston
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More 12/09/16 National
TCR2 Therapeutics Unveils New Cancer Therapy Approach and $44.5M Round 12/08/16 Boston
Page 1 of 13 next page »